Blue Medical Devices BV

June 29, 2023—Translumina, an interventional cardiovascular device company with facilities in Germany and India, announced the acquisition of Blue Medical Devices, a Wellinq group company based in Helmond, the Netherlands. Blue Medical Devices, which was incorporated in 2013, produces drug-coated balloons (DCB) and other balloons for complex coronary interventions. According to Translumina, Blue Medical Devices’ Protégé NC noncompliant and Protégé SC semicompliant DCB catheters have received approval under the European Union’s Medical Devices Regulation. Translumina noted that the devices are designed to overcome the limitations of current DCB technologies and offer high efficacy and safety. They incorporate Blue Medical’s drug application technology that prevents any drug loss during the advancement of the device to the lesion, resulting in high concentration of the drug at the targeted site. The acquisition will also enable Translumina to use Blue Medical’s patented drug application technology in other product lines in peripheral and neurovascular interventions, advised the company. Gurmit Singh Chugh, who along with Punita Sharma founded Translumina in 2010, commented in the company’s press release, “This acquisition is of strategic importance as it complements our next-generation drug-eluting stents portfolio to offer a complete solution for all coronary interventions. Drug-coated balloons are gaining huge significance in treating certain complex lesion subsets and I am confident that this unique technology will provide new treatment possibilities for physicians and patients worldwide.”